Ustekinumab Is Approved for Crohn Disease

Created by:

21 Nov 2016 - General
A new biologic agent was approved for treatment of moderate to severe Crohn Disease. Ustekinumab is the antibody to interleukin-12 and interleukin-23, was initially developed for the treatment of psoriasis and psoriatic arthritis. Ustekinumab is app...
 (Total 106 words)